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ABSTRACT
3-Aminobenzanthrone (3-ABA) is a human metabolite of carcinogenic 3-nitrobenzanthrone (3-NBA), which occurs in diesel exhaust 
and air pollution. Understanding which cytochrome P450 (CYP) enzymes are involved in metabolic activation and/or detoxication of 
this toxicant is important in the assessment of an individual’s susceptibility to this substance. The aim of this study was to evaluate 
the efficiency of rat hepatic CYPs to oxidize 3-ABA and to examine the metabolites formed during such an oxidation. The metabolites 
formed by CYPs in rat hepatic microsomes were separated by high performance liquid chromatography (HPLC). 3-ABA is oxidized by 
these enzymes to three metabolites, which were separated by HPLC as distinguish product peaks. Using co-chromatography with 
synthetic standards, two of them were identified to be oxidative metabolites of 3-ABA, N-hydroxy-3-ABA and 3-NBA. The structure 
of another 3-ABA metabolite remains to be characterized. To define the role of rat hepatic CYP enzymes in metabolism of 3-ABA, 
we investigated the modulation of its oxidation using different inducers of CYPs for treatment of rats to enrich the liver microsomes 
with individual CYPs. Based on these studies, we attribute most of 3-ABA oxidation in rat hepatic microsomes to CYP2B, followed by 
CYP1A, although a role of other hepatic CYPs cannot be ruled out. Inhibition of 3-ABA oxidation by selective inhibitors of individual 
CYPs, supported this finding. 
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carcinogen (Seidel et al., 2002; Arlt, 2005; Nagy et al., 2005). 
The uptake of 3-NBA in humans has been demonstrated, 
because  its  metabolite  3-ABA  has  been  found  in  urine 
samples of salt mine workers occupationally exposed to 
diesel emissions (Seidel et al., 2002). 3-ABA was also the 
main metabolite of 3-NBA formed in human fetal bronchial 
cells and rat lung alveolar type II cells (Borlak et al., 2000). 
In addition, 3-ABA was evaluated to be suitable for color-
ation of microporous polyethylene films, which are widely 
used for practical purposes such as separation of liquid 
mixtures, in particular, as separation membranes in chemi-
cal batteries (Grabchev et al., 2002), or an advantageous 
fluorescent phospholipid membrane label in the form of its 
N-palmitoyl derivative (Sykora et al., 2002). This suggests 
its industrial and/or laboratory utilization. Furthermore, 
genotoxicity of 3-NBA and 3-ABA has been documented 
by the detection of specific DNA adducts formed in vitro as 
well as in vivo in rodents in various tissues (Arlt et al., 2001; 
2002; 2003a; b; c; 2004a; c; 2005; 2006b; Bieler et al., 1999; 
2005; 2007; Stiborová et al., 2006; 2008). The predominant 
Introduction
3-Aminobenzanthrone (3-ABA, Figure 1) is the reductive 
metabolite of the carcinogenic environmental pollutant, 
nitroketone  3-nitrobenzanthrone  (3-nitro-7H-benz[de]
anthracen-7-one, 3-NBA, Figure 1) (Hansen et al., 2007; 
Svobodová et al., 2007). In recent years 3-NBA has received 
much attention due to its presence in diesel exhaust and its 
extremely high mutagenic potency in the Ames Salmonella 
assay (Enya et al., 1997; Seidel et al., 2002; Arlt, 2005). 
3-NBA is carcinogenic in rats, causing lung tumours after 
intratracheal instillation, and it is also a suspected human 
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DNA adducts formed form 3-NBA and 3-ABA are N-(2’-
deoxyguanosin-N2-yl)-3-aminobenzanthrone (dG-N2-ABA) 
and N-(2’-deoxyguanosin-8-yl)-3-aminobenzanthrone (dG-
C8-N-ABA) and these are most probably responsible for the 
induction of GC to TA transversion mutations induced by 
these toxicants (Arlt et al., 2004a; Arlt et al., 2006b; Bieler 
et al., 2007). 
Even though the epidemiological study on the toxicity 
of 3-ABA has not yet been evaluated, formation of DNA 
adducts by this reductive metabolite of 3-NBA in vitro and 
in vivo in rodents inducing these transversion mutations 
indicates its potential genotoxicity. Understanding which 
enzymes are involved in the metabolism (activation and/
or detoxication) of 3-ABA is important in the assessment 
of susceptibility to this 3-NBA metabolite. Recently, we 
have found that cytochromes P450 (CYP) 1A1 and 1A2 are 
essential for 3-ABA oxidative activation in human and rat 
livers, forming the same DNA adducts that are formed in 
vivo by 3-ABA or 3-NBA (Arlt et al., 2004b). CYP1A1 is also 
efficient activator of 3-ABA in microsomes of rat kidneys 
and lungs, while prostaglandin H synthase (cyclooxygenase) 
plays a minor role in this subcellular fraction (Stiborová et al., 
2008). Previous results also indicate that besides microsomal 
CYP enzymes cytosolic peroxidases might play a role in the 
oxidative activation of 3-ABA, mainly in extrahepatic tis-
sues such as kidneys and lungs (Arlt et al., 2006a, Stiborová 
et al., 2006; 2008). In in vitro experiments, mammalian 
cyclooxygenase, lactoperoxidase and myeloperoxidase were 
found to be effective in activating 3-ABA (Arlt et al., 2006a) 
(Figure 1).
In contrast to the enzymes activating 3-ABA to species 
binding to DNA, those participating in 3-ABA oxidation 
to other potential metabolites have not been extensively 
studied so far. Therefore, here we investigated the oxidative 
metabolism of 3-ABA in vitro, in order to characterize the 
3-ABA metabolites and to identify CYPs responsible for 
their formation. Hepatic microsomes of untreated (control) 
rats and those treated with two CYP inducers, namely, 
β-naphthoflavone (β-NF), which induces CYP1A and phe-
nobarbital (PB), which induces CYP2B, were used for such 
a study. The selective inhibitors of individual CYP enzymes 
were also utilized to identify the most important enzymes 
oxidizing 3-ABA. 
Materials and methods
Synthesis of 3-ABA and N-hydroxy-3-ABA (N-OH-ABA)
3-ABA  and  N-OH-ABA  were  synthesized  as  described 
(Arlt et al., 2003a) and their authenticity was confirmed by 
UV spectroscopy, electrospray mass spectra and high field 
proton NMR spectroscopy.
Animal experiments and preparation of microsomes
The  study  was  conducted  in  accordance  with  the 
Regulations for the Care and Use of Laboratory Animals 
(311/1997, Ministry of Agriculture, Czech Republic), which 
complies with Declaration of Helsinki. Microsomes from 
livers of ten male untreated Wistar rats and those of rats 
pretreated with β-NF (Sigma, UK) and PB were prepared by 
the procedure described previously (Stiborová et al., 2002). 
Rat liver microsomes contained 0.6 nmol CYP/mg protein. 
Hepatic microsomes of rats treated with β-NF and PB con-
tained 1.3 and 1.5 nmol CYP/mg proteins, respectively. 
Incubations
Incubation mixtures, in a final volume of 500 µl, consisted 
of 100 mM potassium phosphate buffer (pH 7.4), 10 mM 
NADPH,  0.5 mg  of  microsomal  protein  and  5–50 μM 
3-ABA (dissolved in dimethyl sulfoxide, DMSO). The reac-
tion was initiated by adding 3-ABA. Incubations with rat 
microsomes were carried out at 37 °C for 5–180 minutes. 
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Figure 1. Pathways of metabolic activation and DNA adduct formation of 3-aminobenzanthrone and 3-nitrobenzanthrone. See the text for 
details.  R  =  -COCH3  or  -SO3H;  dA-N6-ABA,  2-(2’-deoxyadenosin-N6-yl)-3-aminobenzanthrone;  dG-N2-ABA,  N-(2’-deoxyguanosin-N2-yl)-3-ami-
nobenzanthrone; dG-C8-N-ABA, N-(2’-deoxyguanosin-8-yl)-3-aminobenzanthrone.152
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Control incubations were carried out either (1) without the 
enzymatic system (microsomes) or (2) with microsomes and 
3-ABA, but without NADPH. Then, 5 µl of 1 mM phena-
cetine in methanol was added as an internal standard and 
3-ABA and its metabolites were extracted twice with ethyl 
acetate (2 × 1.5 ml). The extracts were evaporated to dryness; 
residues were dissolved in 30 µl of methanol and subjected 
to reverse-phase (RP)-HPLC to evaluate the amounts of 
residual 3-ABA and its metabolites. 
HPLC 
The HPLC was performed with a reversed phase column 
(Nucleosil 100-5 C18, Macherey-Nagel, Duren, Germany, 25 
cm × 4.6 mm, 5 µm) proceeded by a C-18 guard column, 
using isocratic elution conditions of 70% methanol in dis-
tilled water with a flow rate of 0.6 ml/min. The HPLC was 
carried out with a Dionex HPLC pump P580 with UV/VIS 
UVD 170S/340S spectrophotometer detector set at 254 nm, 
and peaks were integrated with a CHROMELEONTM 6.01 
integrator.
Inhibition studies 
The  following  chemicals  were  used  to  inhibit  3-ABA 
oxidation  in  the  presence  of  rat  hepatic  microsomes: 
α-naphthoflavone (α-NF), which inhibits CYP1A1 and 1A2, 
furafylline, which inhibits CYP1A2, diamantane, an inhibi-
tor of CYP2B, sulfophenazole, which inhibits CYP2C and 
diethyldithiocarbamate, which inhibits CYP2E1 (Rendic 
and DiCarlo, 1997). Inhibitors were dissolved in 7.5 µl of 
methanol or water (in the case of diethyldithiocarbamate), to 
yield final concentrations of 0.01–0.1 mM in the incubation 
mixtures. Mixtures were then incubated at 37 °C for 5 min 
with NADPH prior to adding 3-ABA, and then incubated 
for a further 20 min at 37 °C. After the incubation, 3-ABA 
and its metabolites were extracted and analyzed by HPLC 
as described above.
Results
3-Aminobenzanthrone  is  oxidized  by  rat  hepatic  CYP 
enzymes  in  microsomes  up  to  three  metabolites  (see 
Figure 2 for hepatic microsomes of rats treated with β-NF). 
These metabolites were separated by HPLC as distinguish 
product peaks (Figure 2A). Using co-chromatography with 
synthetic standards, two of them were identified to be the 
oxidative metabolites of 3-ABA (Figure 2B), N-hydroxy-
3-ABA (Figure 2C) and 3-NBA (Figure 2D). Structures of 
another metabolite eluted with the retention time (r.t.) of 
18 min, M18 (Figure 2A), remains to be characterized. 
In order to evaluate the role of the rat hepatic CYPs in 
oxidation of 3-ABA, hepatic microsomes of rats treated with 
inducers of several CYPs (β-NF as an inducer of CYP1A1/2 
and  PB  as  an  inducer  of  CYP2B)  were  used.  All  these 
microsomes as well as those of the untreated (control) rats 
were capable of oxidizing 3-ABA. Under the experimental 
conditions used, the most efficient microsomes oxidizing 
3-ABA were those isolated from livers of rats treated with 
PB (rich in CYP2B), followed by those isolated from livers 
of rats treated with β-NF (rich in CYP1A) and by control 
microsomes (Figure 3). This finding suggests that CYPs of 
a 2B subfamily, followed by those of a 1A subfamily might 
play an important role in 3-ABA oxidation. Whereas hepatic 
microsomes  rich  in  CYP1A  (β-NF-microsomes)  gener-
ated the final oxidative metabolite of 3-ABA, 3-NBA, this 
metabolite was not generated by other microsomes tested 
in this study. The metabolite with unknown structure, M18, 
was only formed from 3-ABA by these enzymatic systems 
(Figure 3)
The role of rat hepatic CYP enzymes in 3-ABA oxidation 
was further investigated by modulation of this reaction by 
selective inhibitors of individual CYPs. Of the inhibitors 
used in the study, diamantane, an inhibitor of CYP2B, was 
the most efficient inhibitor of 3-ABA oxidation with the IC50 
 
3-NBA
M18
N-OH-ABA
-10.9
0.0
10.0
20.0
36.4
0.5 5.0 7.5 10.0 12.5 15.0 17.5 20.0 22.5 25.0 27.5 30.0 32.5 35.0 37.5 41.6
mAU
min
3-ABA s Beta NF MS1 120´ UV_VIS_1
1 - 4.892
2 - 6.294
3 - 8.272
4 - 13.648
5 - 18.714
6 - 25.666
WVL:254 nm
3-ABA
- -
-10.9
0.0
10.0
20.0
36.4
0.5 5.0 7.5 10.0 12.5 15.0 17.5 20.0 22.5 25.0 27.5 30.0 32.5 35.0 37.5 41.6
3-ABA s Beta NF MS1 120´ UV_VIS_1
1 - 4.892
2 - 6.294
3 - 8.272
4 - 13.648
5 - 18.714
6 - 25.666
WVL:254 nm
-
- -
-10.9
0.0
10.0
20.0
36.4
0.5 5.0 7.5 10.0 12.5 15.0 17.5 20.0 22.5 25.0 27.5 30.0 32.5 35.0 37.5 41.6
3-ABA s Beta NF MS1 120´ UV_VIS_1
1 - 4.892
2 - 6.294
3 - 8.272
4 - 13.648
5 - 18.714
6 - 25.666
WVL:254 nm
-
-10.9
0.0
10.0
20.0
36.4
0.5 5.0 7.5 10.0 12.5 15.0 17.5 20.0 22.5 25.0 27.5 30.0 32.5 35.0 37.5 41.6
3-ABA s Beta NF MS1 120´ UV_VIS_1
1 - 4.892
2 - 6.294
3 - 8.272
4 - 13.648
5 - 18.714
6 - 25.666
WVL:254 nm
- -
-10.9
0.0
10.0
20.0
36.4
0.5 5.0 7.5 10.0 12.5 15.0 17.5 20.0 22.5 25.0 27.5 30.0 32.5 35.0 37.5 41.6
3-ABA s Beta NF MS1 120´ UV_VIS_1
1 - 4.892
2 - 6.294
3 - 8.272
4 - 13.648
5 - 18.714
6 - 25.666
WVL:254 nm
-10.9
0.0
10.0
20.0
36.4
0.5 5.0 7.5 10.0 12.5 15.0 17.5 20.0 22.5 25.0 27.5 30.0 32.5 35.0 37.5 41.6
3-ABA s Beta NF MS1 120´ UV_VIS_1
1 - 4.892
2 - 6.294
3 - 8.272
4 - 13.648
5 - 18.714
6 - 25.666
WVL:254 nm  
-50
100
200
350
0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.0 11.0 12.0 13.6
mAU
min
10,0nmolární 3-ABA UV_VIS_1
1 - 8.214
WVL:254 nm
3-ABA
-50
100
200
350
0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.0 11.0 12.0 13.6
10,0nmolární 3-ABA UV_VIS_1
1 - 8.214
WVL:254 nm
-50
100
200
350
0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.0 11.0 12.0 13.6
10,0nmolární 3-ABA UV_VIS_1
1 - 8.214
WVL:254 nm
 
N-OH-ABA
-0.73
0.00
1.00
2.60
0.1 2.5 5.0 7.5 10.0 12.5 15.0 17.5 20.0 22.5 25.0 27.5 30.0 32.5 35.0 37.5 40.0 44.5
mAU
min
standard N-OH-3ABA 1mikromolarní UV_VIS_1
1 - 5.906
2 - 6.651
3 - 9.800 4 - 25.293 5 - 32.498
WVL:254 nm
standard N-OH-3ABA 1mikromolarní UV_VIS_1
WVL:254 nm
standard N-OH-3ABA 1mikromolarní UV_VIS_1
WVL:254 nm  
3-NBA
-100
500
1200
0.0 2.0 4.0 6.0 8.0 10.0 12.0 14.0 16.0 18.0 20.0 22.0 24.0 26.0 28.0 29.8
mAU
min
3-NBA 10 nmol UV_VIS_1
1 - 24.751
WVL:254 nm
-100
500
1200
0.0 2.0 4.0 6.0 8.0 10.0 12.0 14.0 16.0 18.0 20.0 22.0 24.0 26.0 28.0 29.8
3-NBA 10 nmol UV_VIS_1
1 - 24.751
WVL:254 nm
-100
500
1200
0.0 2.0 4.0 6.0 8.0 10.0 12.0 14.0 16.0 18.0 20.0 22.0 24.0 26.0 28.0 29.8
3-NBA 10 nmol UV_VIS_1
1 - 24.751
WVL:254 nm
A
C D
B
Figure 2. HPLC of 3-ABA metabolites produced by hepatic microsomes of rats treated with β-NF (A), HPLC of 3-ABA (B), N-hydroxy-3-ABA (C) 
and 3-NBA (D). 153
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Discussion
3-ABA, the human metabolite of the ubiquitous environ-
mental pollutant 3-NBA, was detected in the urine of smok-
ing and nonsmoking salt mining workers occupationally 
exposed to diesel emissions at similar concentration (1–143 
ng/24 h urine) to 1-aminopyrene (2–200 ng/24 h urine), the 
corresponding amine of the most abundant nitro-polycyclic 
aromatic hydrocarbons detected in diesel exhaust matter 
(Seidel et al., 2002). The present study has increased our 
knowledge on the potential of CYP enzymes to oxidize this 
toxicant and on the kinetics of such an oxidation. 
The rat was used as an experimental model on the basis 
that the same enzymes activate 3-ABA in human and rat 
livers to species forming DNA adducts (Arlt et al., 2004b, 
2006a; Stiborová et al., 2006). Therefore, the results should 
provide some indication of what might occur with 3-ABA 
in livers of humans. Rat and human hepatic CYP1A1 and/
or 1A2 were found to be responsible for metabolic activa-
tion of 3-ABA (Arlt et al., 2004b). This finding corresponds 
to results found in the present study. Here, we have found 
that CYP1A enzymes are effective in oxidation of 3-ABA 
to the final oxidative metabolite of this compound, 3-NBA. 
Namely, to the metabolite that is formed through the for-
mation of N-hydroxy-3-ABA. This reactive intermediate is, 
however, also decomposed to the ultimate carcinogenic spe-
cies of 3-ABA, nitrenium and/or carbenium ions, forming 
3-ABA-derived DNA adducts. Hence, this metabolic activa-
tion pathway seems to be the prevalent pathway of CYP1A 
enzymes. On the contrary, the CYP enzymes of the 2B 
subfamily (PB-microsomes), which were the most effective 
in oxidation of 3-ABA, did not form 3-NBA. Likewise, such 
a pathway was also not found for CYPs expressed in livers 
of untreated rats. Therefore, these CYP enzymes seem to 
play a detoxication role in 3-ABA metabolism. Nevertheless, 
this finding needs to be confirmed by additional studies. 
For example, the structural characterization of the 3-ABA 
metabolite M18 might shed some light on this feature. 
In  conclusion,  the  study  showing  for  the  first  time 
identification of two metabolites formed from 3-ABA by 
CYP-mediated oxidation, confirmed the participation of 
CYP1A enzymes in activation of 3-ABA, namely, in forma-
tion of such a metabolite of 3-ABA, which is responsible for 
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Figure 3. Time dependence of 3-ABA oxidation by hepatic micro-
somes of rats treated with β-NF (A), PB (B), and untreated (control 
microsomes) (C).
table 1. 
The values of IC50 for inhibition of 3-ABA oxidation by CYPs. 
Hepatic microsomes from 
rats pretreated with inhibitor ic50 [μM]
β-naphtoflavone
(CYP1A1/2)
α-naphtoflavone
(CYP1A1/2) 10.9
β-naphtoflavone
(CYP1A1/2)
Furafylline
(CYP1A2) 16.6
Control DDTC
(CYP2E1) 96.8
Control Sulfaphenazole
(CYP2C) 10.8
Phenobarbital
(CYP2B)
Diamantane
(CYP2B) 0.9
value of 0.9 µM, followed by α-NF, sulfaphenazole and fura-
fylline, inhibitors of CYP1A1/2, 2C and 1A2, respectively. 
The lowest inhibition efficacy was found for an inhibitor 
of CYP2E1, diethyldithiocarbamate. The IC50 values are 
shown in Table 1. These results supported the data found 
in the experiments with CYP inducers; CYP2B, followed by 
CYP1A, seem to be the most efficient in 3-ABA oxidation, 
whereas other CYP enzymes are less effective.154
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